MY110751A - Positive inotropic and lusitropic pyrroloquinolinone derivatives - Google Patents

Positive inotropic and lusitropic pyrroloquinolinone derivatives

Info

Publication number
MY110751A
MY110751A MYPI94001564A MYPI19941564A MY110751A MY 110751 A MY110751 A MY 110751A MY PI94001564 A MYPI94001564 A MY PI94001564A MY PI19941564 A MYPI19941564 A MY PI19941564A MY 110751 A MY110751 A MY 110751A
Authority
MY
Malaysia
Prior art keywords
lusitropic
positive inotropic
pyrroloquinolinone
derivatives
compounds
Prior art date
Application number
MYPI94001564A
Inventor
Jean Edgard Freyne Eddy
Herman Margaretha Raeymaekers Alfons
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MY110751A publication Critical patent/MY110751A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

THE PRESENT INVENTION RELATES TO NOVEL POSITIVE INOTROPIC AND LUSITROPIC COMPOUNDS OF FORMULA THE PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS THEREOF AND THE STEROECHEMICALLY ISOMERIC FORMS THEREOF WHEREIN L IS A RADICAL OF FORMULA -O-ALK-(NH)P -C(=O)R1, PHARMACEUTICAL COMPOSITIONS THEREOF, METHODS OF PREPARING SAID COMPOUNDS AND INTERMEDIATES IN THE PREPARATION THEREOF.
MYPI94001564A 1993-06-21 1994-06-17 Positive inotropic and lusitropic pyrroloquinolinone derivatives MY110751A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93201771 1993-06-21

Publications (1)

Publication Number Publication Date
MY110751A true MY110751A (en) 1999-02-27

Family

ID=8213908

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI94001564A MY110751A (en) 1993-06-21 1994-06-17 Positive inotropic and lusitropic pyrroloquinolinone derivatives

Country Status (29)

Country Link
US (1) US5602134A (en)
EP (1) EP0707586B1 (en)
JP (1) JP2812804B2 (en)
KR (1) KR0181560B1 (en)
CN (1) CN1043765C (en)
AT (1) ATE171179T1 (en)
AU (1) AU679077B2 (en)
BG (1) BG62171B1 (en)
BR (1) BR9406899A (en)
CA (1) CA2163122C (en)
CZ (1) CZ284350B6 (en)
DE (1) DE69413398T2 (en)
FI (1) FI109124B (en)
HU (1) HU220670B1 (en)
IL (1) IL110055A (en)
LT (1) LT3447B (en)
LV (1) LV11545B (en)
MY (1) MY110751A (en)
NO (1) NO305366B1 (en)
OA (1) OA10202A (en)
PH (1) PH31308A (en)
PL (1) PL176783B1 (en)
RU (1) RU2129554C1 (en)
SG (1) SG49717A1 (en)
SI (1) SI9420041A (en)
SK (1) SK280400B6 (en)
TW (1) TW593317B (en)
WO (1) WO1995000512A1 (en)
ZA (1) ZA944382B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA72611C2 (en) * 2000-05-17 2005-03-15 Орто-Макнейл Фармацевтикал, Інк. Derivatives of substituted pyrrolopyridinone useful as phosphodiesterase inhibitors
US7208497B2 (en) 2001-07-02 2007-04-24 Novo Nordisk A/S Substituted piperazines and diazepanes
US20030186963A1 (en) 2001-09-14 2003-10-02 Dorwald Florencio Zaragoza Substituted piperidines
EP1434765B1 (en) * 2001-09-14 2009-12-02 High Point Pharmaceuticals, LLC Substituted piperidines with selective binding to histamine h3-receptor
GB0522715D0 (en) * 2005-11-08 2005-12-14 Helperby Therapeutics Ltd New use
TWI498115B (en) * 2007-12-27 2015-09-01 Daiichi Sankyo Co Ltd Imidazole carbonyl compound
GB0808944D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substituted quinazolines
GB0808953D0 (en) * 2008-05-16 2008-06-25 Shire Llc substituted quinazolines
RU2457208C2 (en) * 2009-07-06 2012-07-27 Государственное образовательное учреждение высшего профессионального образования "Пермская государственная фармацевтическая академия Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО "ПГФА Росздрава") 1H-PYRROLO[3,4-b]QUINOLINE-3,9(2H,4H)-DIONES EXHIBITING ANTI-TUBERCULOSIS ACTIVITY AND METHOD FOR PREPARING THEM
CN120265631A (en) * 2023-01-13 2025-07-04 上海超阳药业有限公司 Quinolinone compounds and naphthyridone compounds and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3578374D1 (en) * 1984-01-13 1990-08-02 Boots Co Ltd USE OF CHINOLONES FOR THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF HEART DISEASES.
US4668686A (en) * 1985-04-25 1987-05-26 Bristol-Myers Company Imidazoquinoline antithrombrogenic cardiotonic agents
US4775674A (en) 1986-05-23 1988-10-04 Bristol-Myers Company Imidazoquinolinylether derivatives useful as phosphodiesterase and blood aggregation inhibitors
SU1527588A1 (en) * 1987-01-16 1989-12-07 Саратовский государственный медицинский институт Method of determining allergic reactions to medicine
NZ234186A (en) * 1989-07-07 1991-10-25 Janssen Pharmaceutica Nv Imidazo quinazolin-one derivatives and pharmaceutical compositions
CN1030196C (en) * 1989-07-07 1995-11-01 詹森药业有限公司 Positive inotropic and lusitropic 3,5-dihydro-imidazo [2,1-6] quinazolin-2(1H)-one derivatives
US5220023A (en) * 1989-07-18 1993-06-15 Janssen Pharmaceutica N.V. Glycine derivatives
US4943573A (en) * 1989-11-01 1990-07-24 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
US5196428A (en) * 1992-04-03 1993-03-23 Bristol-Myers Squibb Company Imidazo[4,5-b]qinolinyl oxy alkyl ureas

Also Published As

Publication number Publication date
ZA944382B (en) 1995-12-20
DE69413398T2 (en) 1999-04-15
TW593317B (en) 2004-06-21
NO955028L (en) 1995-12-12
ATE171179T1 (en) 1998-10-15
NO955028D0 (en) 1995-12-12
NO305366B1 (en) 1999-05-18
US5602134A (en) 1997-02-11
FI956143A0 (en) 1995-12-20
JP2812804B2 (en) 1998-10-22
LV11545B (en) 1997-08-20
KR0181560B1 (en) 1999-05-01
CZ336695A3 (en) 1996-03-13
FI956143L (en) 1995-12-20
BG100209A (en) 1996-07-31
CN1043765C (en) 1999-06-23
PH31308A (en) 1998-07-06
JPH09500108A (en) 1997-01-07
RU2129554C1 (en) 1999-04-27
LV11545A (en) 1996-10-20
HUT72090A (en) 1996-03-28
FI109124B (en) 2002-05-31
LT3447B (en) 1995-10-25
EP0707586B1 (en) 1998-09-16
BR9406899A (en) 1996-04-09
LTIP1960A (en) 1995-01-31
CN1125945A (en) 1996-07-03
AU7000894A (en) 1995-01-17
IL110055A0 (en) 1994-10-07
SG49717A1 (en) 1998-06-15
SK280400B6 (en) 2000-01-18
HU220670B1 (en) 2002-04-29
IL110055A (en) 1997-09-30
AU679077B2 (en) 1997-06-19
DE69413398D1 (en) 1998-10-22
EP0707586A1 (en) 1996-04-24
CZ284350B6 (en) 1998-10-14
OA10202A (en) 1996-12-18
PL312252A1 (en) 1996-04-01
CA2163122A1 (en) 1995-01-05
WO1995000512A1 (en) 1995-01-05
SI9420041A (en) 1996-08-31
SK159695A3 (en) 1997-01-08
HU9501970D0 (en) 1995-09-28
CA2163122C (en) 2005-06-14
PL176783B1 (en) 1999-07-30
BG62171B1 (en) 1999-04-30

Similar Documents

Publication Publication Date Title
JPS5630964A (en) Novel substituted quinolinecarboxylic acid and its preparation
CA2033392A1 (en) A-nor-steroid-3-carboxylic acid derivatives
EP0353955A3 (en) Novel compounds
GR3015461T3 (en) 7-Keto- and 7-Hydroxy-androsta-3,5-diene-3-carboxylic acid derivatives.
MY110751A (en) Positive inotropic and lusitropic pyrroloquinolinone derivatives
CA2226406A1 (en) Novel pyridone carboxylic acid derivatives
ES8405005A1 (en) New ribofuranuronic acid derivatives, processes for preparation thereof and pharmaceutical compositions thereof.
IL85919A0 (en) Pharmaceutical compositions for improving sleep comprising n-aryl-piperazinealkanamide derivatives,certain such novel compounds and their preparation
MY103502A (en) Novel compounds
EP0147181A3 (en) Thiazolylacetic acid derivatives and their preparation
TW339325B (en) Novel azepane derivatives, process for the preparation thereof and pharmaceutical composition containing the same
GB9324931D0 (en) Glutaramide derivatives
ES8507123A1 (en) 4-alkyl-2-hydroxy-3-methyl-2-phenyl-morpholine derivatives, process for their preparation and their therapeutical use
TW262467B (en)
ES8304973A1 (en) Beta-lactam antibiotics, their preparation and use.
GR81771B (en)
ES8401957A1 (en) Preparation of thiophene compounds
SE8502310L (en) NEW CINOLINE DERIVATIVES, SET TO MAKE THESE AND THERAPEUTIC COMPOSITIONS, CONTAINING THEM
ES482462A1 (en) A process for preparing cis-2-aryl-3-aminomethyl-bicyclo (2,2,2) octanes and the compounds 2-aryl-3-aminomethylidene-bicyclo (2,2,2) octanes.
GB1512359A (en) 2-styrylbenztriazoles their preparation and use as optical brighteners
ES482083A1 (en) Tetrahydro-2H-benzo(c)pyrroles, their preparation, pharmaceutical compositions containing them and the compounds for use as therapeuticals.
ES8307782A1 (en) Derivatives of the 3-amino-1-heteroaryloxy-2-propanol class, their use in therapy and a process for their preparation.